IL1B and neoplasm: Autologous DC vaccines, created with tumor cells cultured in interleukin 4 (IL4), granulocyte-macrophage colony-stimulating factor preceding maturation with IL-1B and tumor necrosis factor alpha, were shown to prolong survival and remission control in three young children with safe administration an minimal side effects [48].